Skip to main content
JAMA Network logoLink to JAMA Network
. 2025 Aug 20;161(10):1094. doi: 10.1001/jamadermatol.2025.3297

Error in Methods

PMCID: PMC12368781  PMID: 40833739

In the Original Investigation titled “Comparison of Botulinum Toxin A Formulations for Glabellar Strain Treatment in Women: A Double-Blind Randomized Clinical Trial,”1 published online on May 28, 2025, and in the July 2025 issue, there was an error in the Methods section. The sentence “All reconstitutions were performed with 2.5 mL of sterile saline solution per a 100-unit or 300-unit (ABoNT/A) vial, and all treatments were performed with 0.2 mL of product” should be “Reconstitutions were performed with 2.5 mL of sterile saline per 100 units (OBoNT/A, PBoNT/A, IBoNT/A) or 3.0 mL per 300 unit (ABoNT/A) vial and each injection point was treated with 0.1 mL of product,” and in the previous sentence, “60 units” should be “50 units.” This article was corrected online.

Reference

  • 1.Lemdani MS, Honig SE, Habarth-Morales TE, et al. Comparison of botulinum toxin A formulations for glabellar strain treatment in women: a double-blind randomized clinical trial. JAMA Dermatol. 2025;161(7):723-730. doi: 10.1001/jamadermatol.2025.1335 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Dermatology are provided here courtesy of American Medical Association

RESOURCES